Nuformix plc (LON: NFX) has appointed Tim Metcalfe as Non-Executive Chairman, with the role taking effect from 1 September 2026.
Nuformix Reports Positive NXP002 Inhalation Study Results
Nuformix plc (LON: NFX) has reported positive preclinical results for NXP002, its potential inhaled treatment for idiopathic pulmonary fibrosis and other progressive fibrosing lung diseases.
4d Pharma PLC (DDDD.L) COVID-19 study open for enrolment
Phase II study of MRx-4DP0004 in patients hospitalized with COVID-19 open for enrolment